Antibacterial composites with encapsulated drug were fabricated via melt blending.
Accelerated hydrolytic degradation kinetics was obtained using a novel method.
Incorporation of LATC30 increases hydrolytic degradation rate and hydrophilicity.
Activation energy and crystallinity both decreased upon addition of LATC30.
Optimum composite is suitable for bone tissue engineering and medical applications.